Electrocardiographic, echocardiographic and ventriculographic characterization of hypertrophic non-obstructive

European Heart Journal
|November 1, 1983
PubMed

Insights

Hypertrophic cardiomyopathy (HCM) presents in various forms, including apical hypertrophy. While genetics play a role, environmental factors also influence myocardial hypertrophy, with specific patterns linked to distinct ECG abnormalities.

Area of Science:

  • Cardiology
  • Genetics
  • Internal Medicine

Background:

  • Hypertrophic cardiomyopathy (HCM) encompasses diverse morphological patterns, including apical hypertrophy (AH) and asymmetrical septal hypertrophy (ASH).
  • While genetic factors underpin HCM, non-genetic influences like hypertension and aging contribute to myocardial hypertrophy, particularly in HNCM.
  • Distinguishing between different HCM morphologies is crucial for understanding disease mechanisms and clinical presentation.

Purpose of the Study:

  • To differentiate the etiological and morphological characteristics of different patterns of hypertrophic cardiomyopathy (HCM).
  • To investigate the relationship between specific hypertrophic patterns and electrocardiographic (ECG) abnormalities.
  • To clarify the role of genetic versus environmental factors in the development of myocardial hypertrophy.

Main Methods:

  • Comparative analysis of clinical and etiological features of different HCM subtypes (HNCM, HOCM, ASH, apical hypertrophy).
  • Correlation of specific left ventricular hypertrophy patterns with characteristic ECG findings.
  • Review of existing literature on the pathophysiology of myocardial hypertrophy in response to various stimuli.

Main Results:

  • HNCM exhibits more diffuse hypertrophy than HOCM, though both share genetic origins.
  • Apical hypertrophy is specifically associated with characteristic ECG abnormalities, including giant negative T waves and high QRS voltage.
  • Abnormal Q waves and left axis deviation suggest marked septal hypertrophy and potential conduction disturbances.

Conclusions:

  • Apical hypertrophy is a distinct morphological pattern in HCM with specific ECG markers, differentiating it from other forms.
  • While genetics are fundamental, HNCM development involves abnormal myocardial response to stimuli like hypertension and aging.
  • ECG findings provide valuable insights into localized hypertrophy and septal involvement in HCM.

Related Concept Videos

Imaging Studies for Cardiovascular System I:Echocardiography01:17

Imaging Studies for Cardiovascular System I:Echocardiography

Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
1.0K
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
564
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
500
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
828
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
810
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
761